KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Common Equity (2016 - 2025)

Historic Common Equity for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $44.0 billion.

  • Elevance Health's Common Equity rose 627.63% to $44.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $44.0 billion, marking a year-over-year increase of 627.63%. This contributed to the annual value of $44.0 billion for FY2025, which is 627.63% up from last year.
  • Elevance Health's Common Equity amounted to $44.0 billion in Q4 2025, which was up 627.63% from $44.1 billion recorded in Q3 2025.
  • In the past 5 years, Elevance Health's Common Equity ranged from a high of $44.1 billion in Q3 2025 and a low of $33.9 billion during Q1 2021
  • Its 5-year average for Common Equity is $39.1 billion, with a median of $38.4 billion in 2023.
  • Its Common Equity has fluctuated over the past 5 years, first surged by 46.18% in 2022, then surged by 1385.61% in 2024.
  • Elevance Health's Common Equity (Quarter) stood at $36.2 billion in 2021, then increased by 0.46% to $36.3 billion in 2022, then grew by 8.46% to $39.4 billion in 2023, then rose by 5.13% to $41.4 billion in 2024, then grew by 6.28% to $44.0 billion in 2025.
  • Its last three reported values are $44.0 billion in Q4 2025, $44.1 billion for Q3 2025, and $43.9 billion during Q2 2025.